Kenneth W. Yip
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Papers in
-
- Cell death mechanisms and regulation 6
- Circular RNAs in diseases 6
- RNA Interference and Gene Delivery 4
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 8
- Co-authors
- John C. Reed (5 shared papers)Fei‐Fei Liu (32 shared papers)Jeff Bruce (8 shared papers)Xiao Zhao (3 shared papers)Jennifer Kwan (5 shared papers)Peter P. Liu (1 shared paper)Tara Spence (3 shared papers)Scott V. Bratman (5 shared papers)
- Journals
- Clinical Cancer Research (5 papers)PLoS ONE (3 papers)Molecular Imaging (2 papers)Oncotarget (2 papers)SLAS DISCOVERY (2 papers)
- Partner nations
- CanadaUnited StatesHong Kong
In The Last Decade
Kenneth W. Yip
39 papers receiving 2.7k citations
Kenneth W. Yip's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 569
- Otorhinolaryngology 151
- Molecular Biology 1.3k
- Oncology 433
- Toxicology 46
Countries citing papers authored by Kenneth W. Yip
This map shows the geographic impact of Kenneth W. Yip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth W. Yip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth W. Yip more than expected).
Fields of papers citing papers by Kenneth W. Yip
This network shows the impact of papers produced by Kenneth W. Yip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth W. Yip. The network helps show where Kenneth W. Yip may publish in the future.
Co-authors
The 25 scholars most cited alongside Kenneth W. Yip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bcl-2 family proteins and cancer Hit paper breakdown → | 2008 | 723 |
| 2 | Targeting metabolic dysregulation for fibrosis therapy Hit paper breakdown → | 2019 | 366 |
| 3 | 2018 | 171 | |
| 4 | 2015 | 130 | |
| 5 | 2016 | 119 | |
| 6 | 2009 | 110 | |
| 7 | 2016 | 108 | |
| 8 | 2014 | 91 | |
| 9 | 2016 | 87 | |
| 10 | 2006 | 85 | |
| 11 | 2018 | 83 | |
| 12 | 2006 | 61 | |
| 13 | 2006 | 58 | |
| 14 | 2016 | 56 | |
| 15 | 2010 | 52 | |
| 16 | 2016 | 50 | |
| 17 | 2005 | 49 | |
| 18 | 2016 | 49 | |
| 19 | 2018 | 34 | |
| 20 | CTX-M type beta-lactamases among fecal Escherichia coli and Klebsiella pneumoniae isolates in non-hospitalized children and adults. | 2008 | 28 |
About Kenneth W. Yip
Kenneth W. Yip is a scholar working on Molecular Biology, Cancer Research, Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 2.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (8 papers), Cell death mechanisms and regulation (6 papers), Circular RNAs in diseases (6 papers), Head and Neck Cancer Studies (5 papers), RNA Interference and Gene Delivery (4 papers), Virus-based gene therapy research (4 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Cancer Research (569 citations), Otorhinolaryngology (151 citations), Molecular Biology (1.3k citations), Oncology (433 citations) and Toxicology (46 citations). Kenneth W. Yip has collaborated with scholars based in Canada, United States and Hong Kong. Frequent co-authors include John C. Reed, Fei‐Fei Liu, Jeff Bruce, Xiao Zhao, Jennifer Kwan, Peter P. Liu, Tara Spence, Scott V. Bratman, Emma Ito and Carlo Bastianutto. Their work appears in journals such as Clinical Cancer Research, PLoS ONE, Molecular Imaging, Oncotarget and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.